Biocon’s partner US-based Equillium Inc has expanded its ‘EQUALISE’ study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Itolizumab to clinical centers in India, Biocon Ltd said in a regulatory filing. Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said the clinical study for its biologic drug Itolizumab for the possible indication … Read more
Mucormycosis, a fungal infection, is being found in COVID-19 patients and largely in cases of those who are diabetic but there is “no big outbreak”, Niti Aayog Member (Health) V K Paul said on Friday. The situation is being monitored and the treatment for mucormycosis is available, he said. This comes a day after a … Read more
NEW DELHI: The Centre is in consultations with the Russian government for exploring the possibility of cooperation between the two countries for advancing the COVID-19 vaccine in India, Parliament was told on Friday. The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one COVID-19 vaccine developed and approved in … Read more